Logo image of GROV

GROVE COLLABORATIVE HOLDINGS (GROV) Stock Fundamental Analysis

NYSE:GROV - New York Stock Exchange, Inc. - US39957D2018 - Common Stock - Currency: USD

1.22  +0.05 (+4.27%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GROV. GROV was compared to 121 industry peers in the Specialty Retail industry. GROV has a bad profitability rating. Also its financial health evaluation is rather negative. GROV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year GROV has reported negative net income.
GROV had a negative operating cash flow in the past year.
GROV had negative earnings in each of the past 5 years.
In the past 5 years GROV always reported negative operating cash flow.
GROV Yearly Net Income VS EBIT VS OCF VS FCFGROV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -43.49%, GROV is doing worse than 91.74% of the companies in the same industry.
With a Return On Equity value of -174.27%, GROV is not doing good in the industry: 78.51% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -43.49%
ROE -174.27%
ROIC N/A
ROA(3y)-41.12%
ROA(5y)-44.93%
ROE(3y)-250.11%
ROE(5y)-245.83%
ROIC(3y)N/A
ROIC(5y)N/A
GROV Yearly ROA, ROE, ROICGROV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

Looking at the Gross Margin, with a value of 53.75%, GROV belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
In the last couple of years the Gross Margin of GROV has grown nicely.
The Profit Margin and Operating Margin are not available for GROV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.05%
GM growth 5Y8.48%
GROV Yearly Profit, Operating, Gross MarginsGROV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

3

2. Health

2.1 Basic Checks

GROV does not have a ROIC to compare to the WACC, probably because it is not profitable.
GROV has more shares outstanding than it did 1 year ago.
GROV has a better debt/assets ratio than last year.
GROV Yearly Shares OutstandingGROV Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
GROV Yearly Total Debt VS Total AssetsGROV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -11.16, we must say that GROV is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -11.16, GROV is doing worse than 95.87% of the companies in the same industry.
A Debt/Equity ratio of 0.46 indicates that GROV is not too dependend on debt financing.
GROV has a Debt to Equity ratio (0.46) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z -11.16
ROIC/WACCN/A
WACC15.56%
GROV Yearly LT Debt VS Equity VS FCFGROV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

2.3 Liquidity

GROV has a Current Ratio of 1.66. This is a normal value and indicates that GROV is financially healthy and should not expect problems in meeting its short term obligations.
GROV's Current ratio of 1.66 is fine compared to the rest of the industry. GROV outperforms 69.42% of its industry peers.
A Quick Ratio of 0.95 indicates that GROV may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.95, GROV is in the better half of the industry, outperforming 71.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 0.95
GROV Yearly Current Assets VS Current LiabilitesGROV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

GROV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.54%, which is quite impressive.
The Revenue for GROV has decreased by -21.57% in the past year. This is quite bad
The Revenue has been decreasing by -2.69% on average over the past years.
EPS 1Y (TTM)51.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
Revenue 1Y (TTM)-21.57%
Revenue growth 3Y-19.06%
Revenue growth 5Y-2.69%
Sales Q2Q%-17.3%

3.2 Future

GROV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.04% yearly.
Based on estimates for the next years, GROV will show a small growth in Revenue. The Revenue will grow by 0.58% on average per year.
EPS Next Y23.9%
EPS Next 2Y19.04%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.74%
Revenue Next 2Y0.58%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GROV Yearly Revenue VS EstimatesGROV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
GROV Yearly EPS VS EstimatesGROV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -1 -2 -3 -4

0

4. Valuation

4.1 Price/Earnings Ratio

GROV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GROV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GROV Price Earnings VS Forward Price EarningsGROV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GROV Per share dataGROV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

GROV's earnings are expected to grow with 19.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.04%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

GROV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GROVE COLLABORATIVE HOLDINGS

NYSE:GROV (5/12/2025, 4:10:00 PM)

1.22

+0.05 (+4.27%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)04-30 2025-04-30
Earnings (Next)08-06 2025-08-06
Inst Owners29.07%
Inst Owner Change0.47%
Ins Owners9.59%
Ins Owner Change1.06%
Market Cap49.10M
Analysts82.5
Price Target2.55 (109.02%)
Short Float %6.4%
Short Ratio18.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)18.58%
Min EPS beat(2)-36.35%
Max EPS beat(2)73.5%
EPS beat(4)2
Avg EPS beat(4)-1.78%
Min EPS beat(4)-83.01%
Max EPS beat(4)73.5%
EPS beat(8)3
Avg EPS beat(8)-15.51%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.72%
Min Revenue beat(2)-6.92%
Max Revenue beat(2)-0.53%
Revenue beat(4)0
Avg Revenue beat(4)-3.31%
Min Revenue beat(4)-6.92%
Max Revenue beat(4)-0.53%
Revenue beat(8)2
Avg Revenue beat(8)-2.76%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)34.43%
EPS NY rev (1m)0%
EPS NY rev (3m)5.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B 3.03
P/tB 3.03
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)-0.48
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS5.05
BVpS0.4
TBVpS0.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -43.49%
ROE -174.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.75%
FCFM N/A
ROA(3y)-41.12%
ROA(5y)-44.93%
ROE(3y)-250.11%
ROE(5y)-245.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.05%
GM growth 5Y8.48%
F-Score4
Asset Turnover3.13
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.89%
Cap/Sales 0.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.66
Quick Ratio 0.95
Altman-Z -11.16
F-Score4
WACC15.56%
ROIC/WACCN/A
Cap/Depr(3y)47.64%
Cap/Depr(5y)75.11%
Cap/Sales(3y)1.11%
Cap/Sales(5y)1.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
EPS Next Y23.9%
EPS Next 2Y19.04%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.57%
Revenue growth 3Y-19.06%
Revenue growth 5Y-2.69%
Sales Q2Q%-17.3%
Revenue Next Year-4.74%
Revenue Next 2Y0.58%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year114.28%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-4.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.97%
OCF growth 3YN/A
OCF growth 5YN/A